158 related articles for article (PubMed ID: 34381253)
1. Impact of a Pharmacist-Driven MRSA Nasal PCR Protocol on Pneumonia Therapy.
Pham SN; Sturm AC; Jacoby JS; Egwuatu NE; Dumkow LE
Hosp Pharm; 2021 Aug; 56(4):221-227. PubMed ID: 34381253
[No Abstract] [Full Text] [Related]
2. Impact of a Pharmacist-driven Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Protocol on the De-escalation of Empiric Vancomycin in Patients with Pneumonia in a Rural Healthcare Setting.
Dadzie P; Dietrich T; Ashurst J
Cureus; 2019 Dec; 11(12):e6378. PubMed ID: 31938656
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist-Driven Methicillin-Resistant
Marinucci V; Louzon PR; Carr AL; Hayes J; Lopez-Ruiz A; Sniffen J
Ann Pharmacother; 2023 May; 57(5):560-569. PubMed ID: 36039495
[TBL] [Abstract][Full Text] [Related]
4. Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia.
Baby N; Faust AC; Smith T; Sheperd LA; Knoll L; Goodman EL
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137813
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia.
Dunaway S; Orwig KW; Arbogast ZQ; Myers ZL; Sizemore JA; Giancola SE
Int J Clin Pharm; 2018 Jun; 40(3):526-532. PubMed ID: 29721739
[TBL] [Abstract][Full Text] [Related]
6. Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit.
Diep C; Meng L; Pourali S; Hitchcock MM; Alegria W; Swayngim R; Ran R; Banaei N; Deresinski S; Holubar M
Am J Health Syst Pharm; 2021 Dec; 78(24):2236-2244. PubMed ID: 34297040
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist-Driven MRSA Nasal PCR Screening and the Duration of Empirical Vancomycin Therapy for Suspected MRSA Respiratory Tract Infections.
Woolever NL; Schomberg RJ; Cai S; Dierkhising RA; Dababneh AS; Kujak RC
Mayo Clin Proc Innov Qual Outcomes; 2020 Oct; 4(5):550-556. PubMed ID: 33083704
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic de-escalation in pneumonia with pharmacist education and ordering of methicillin-resistant
Doan K; Smoke S
Eur J Hosp Pharm; 2024 Jun; 31(4):327-331. PubMed ID: 36754620
[TBL] [Abstract][Full Text] [Related]
9. Impact of a pharmacist-driven methicillin-resistant
Willis C; Allen B; Tucker C; Rottman K; Epps K
Am J Health Syst Pharm; 2017 Nov; 74(21):1765-1773. PubMed ID: 29070498
[TBL] [Abstract][Full Text] [Related]
10. Impact of the sequential implementation of a pharmacy-driven methicillin-resistant
Pettit NN; Nguyen CT; Lew AK; Pisano J
Infect Control Hosp Epidemiol; 2024 Feb; 45(2):196-200. PubMed ID: 37702044
[TBL] [Abstract][Full Text] [Related]
11. MRSA nasal swab PCR to de-escalate antibiotics in the emergency department.
Sindelar MA; Zepeski AE; Lawler BJ; Johnston SD; Faine BA
Am J Emerg Med; 2022 May; 55():133-137. PubMed ID: 35313228
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia.
Dangerfield B; Chung A; Webb B; Seville MT
Antimicrob Agents Chemother; 2014; 58(2):859-64. PubMed ID: 24277023
[TBL] [Abstract][Full Text] [Related]
13. Implementation of MRSA Nasal Swabs as an Antimicrobial Stewardship Intervention to Decrease Anti-MRSA Therapy in COVID-19 Infection.
DeKerlegand A; Johnston E; Mellor B; Schrack MR; O'Neal C
Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830164
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation Patterns and Cost Avoidance of a Pharmacist-Driven Methicillin-Resistant
Meng L; Pourali S; Hitchcock MM; Ha DR; Mui E; Alegria W; Fox E; Diep C; Swayngim R; Chang A; Banaei N; Deresinski S; Holubar M
Open Forum Infect Dis; 2021 Apr; 8(4):ofab099. PubMed ID: 34386545
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of the Methicillin-Resistant
Stodghill J; Finnigan A; Newcomb AB; Lita E; Liu C; Teicher E
Surg Infect (Larchmt); 2021 Nov; 22(9):889-893. PubMed ID: 33872057
[No Abstract] [Full Text] [Related]
16. Clinical utility of a nasal swab methicillin-resistant Staphylococcus aureus polymerase chain reaction test in intensive and intermediate care unit patients with pneumonia.
Giancola SE; Nguyen AT; Le B; Ahmed O; Higgins C; Sizemore JA; Orwig KW
Diagn Microbiol Infect Dis; 2016 Nov; 86(3):307-310. PubMed ID: 27591173
[TBL] [Abstract][Full Text] [Related]
17. Emergency department methicillin-resistant Staphylococcus aureus nare screen effect on pneumonia treatment duration.
Renzoni AJ; Peksa GD; DeMott JM
Am J Emerg Med; 2021 Jun; 44():68-71. PubMed ID: 33581603
[TBL] [Abstract][Full Text] [Related]
18. Duration of Gram-negative antibiotic therapy in patients with pneumonia prior to and after the implementation of MRSA nasal swabs, an antimicrobial stewardship tool.
Troyer BS; Shigle AJ; Kovacic Scherrer N
J Antimicrob Chemother; 2022 Aug; 77(9):2557-2560. PubMed ID: 35733340
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review of the Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening for MRSA Pneumonia.
Smith MN; Brotherton AL; Lusardi K; Tan CA; Hammond DA
Ann Pharmacother; 2019 Jun; 53(6):627-638. PubMed ID: 30600697
[TBL] [Abstract][Full Text] [Related]
20. Swab Testing to Optimize Pneumonia treatment with empiric Vancomycin (STOP-Vanc): study protocol for a randomized controlled trial.
Freiberg JA; Siemann JK; Qian ET; Ereshefsky BJ; Hennessy C; Stollings JL; Rali TM; Harrell FE; Gatto CL; Rice TW; Nelson GE
Res Sq; 2024 Jun; ():. PubMed ID: 38947088
[No Abstract] [Full Text] [Related]
[Next] [New Search]